#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

News

LDL cholesterol

LDL cholesterol: a new risk factor for the onset of venous thromboembolic disease?

3. 2. 2020 Source: Cardiovascular Risks

Not only do atherosclerotic plaques in the arteries and the risk of heart attack decrease along with LDL cholesterol levels. Results from a large molecular genetic study suggest that lowering its levels might also reduce the risk of venous thromboembolic disease.

Polatuzumab Vedotin in Combination Treatment of Patients with R/R DLBCL

Polatuzumab Vedotin is a conjugate of a cytostatic agent and an antibody against CD79b, a component…
3. 2. 2020 Source: Non-Hodgkin Lymphomas and CLL
zhodnocení výsledků vyšetření u lékaře 2356x1571

End of Unnecessary Biopsies? Prostate Health Index (PHI) in Detecting Aggressive Carcinoma

The Prostate Health Index (PHI) combines the results of three blood-derived parameters: total PSA…
2. 2. 2020 Source: Prostate Health Index
notebook_studie_výzkum_laptop_vzdělávání

Prediction of Cancer Aggressiveness: Prostate Health Index (PHI) as a Promising Future Marker

The Prostate Health Index (PHI) is a diagnostic blood test that combines the levels of…
2. 2. 2020 Source: Prostate Health Index

Cardiovascular Benefit of SGLT2 Inhibitors Confirmed

The cardiovascular (CV) benefit of SGLT2 inhibitors in type 2 diabetics, demonstrated by empagliflozin...
31. 1. 2020 Source: Diabetes
muz_zena_par

Why Do Women in the USA Receive Indicated Statin Therapy Less and in Lower Doses Than Men?

Statin use has been proven to reduce the risk of cardiovascular diseases in both men and women.…
31. 1. 2020 Source: Cardiovascular Risks
obezita_lide_ulice

Efficacy and Safety of High Doses of Enoxaparin in Preventing Thromboembolic Disease in Morbidly Obese Patients

Thromboembolic disease is a significant cause of morbidity and mortality in hospitalized patients,…
28. 1. 2020 Source: Thromboprophylaxis
PL_operace_lekari_monitor

Prophylaxis of Thromboembolism with Low-Molecular-Weight Heparins in Oncology Patients: Efficacy and Safety of Doses Adjusted According to Anti-Xa Activity

Oncological patients undergoing surgical procedures are observed to have a high risk of…
28. 1. 2020 Source: Thromboprophylaxis
biomarker_rakovina_vyzkum_lymfom

Evaluation of the m7-FLIPI score in patients with follicular lymphoma revealed a promising predictive biomarker for determining suitable chemotherapy

The authors of a study presented at the December congress of the American Society of Hematology…
27. 1. 2020 Source: Non-Hodgkin Lymphomas and CLL
samovysetreni_prsa

Kadcyla in a New Indication – Adjuvant Therapy for Early HER2+ Breast Cancer

In December, the European Commission approved the expansion of the indication for Roche's medicinal…
23. 1. 2020 Source: Breast Carcinoma
1 156 157 158 159 160
Filter by speciality
Remove filters

Conferences

News from the world of medicine

16. 1.
Léčba rány
XIII. Celostátní kongres České společnosti pro léčbu rány s mezinárodní účastí

All conferences
Popular this week
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#